Cronos Group (NASDAQ:CRON) Sets New 52-Week Low – Should You Sell?

Cronos Group Inc. (NASDAQ:CRON) shares reached a new 52-week low on Friday . The stock traded as low as $1.86 and last traded at $1.88, with a volume of 67250 shares. The stock had previously closed at $1.87.

Cronos Group Stock Performance

The business’s 50 day moving average price is $2.08 and its 200-day moving average price is $2.22. The firm has a market cap of $745.48 million, a price-to-earnings ratio of -15.00 and a beta of 0.99.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. National Bank of Canada FI raised its position in shares of Cronos Group by 1,094.4% during the 2nd quarter. National Bank of Canada FI now owns 15,169 shares of the company’s stock valued at $35,000 after acquiring an additional 13,899 shares in the last quarter. Quantbot Technologies LP bought a new stake in Cronos Group during the third quarter valued at $37,000. Headlands Technologies LLC raised its holdings in shares of Cronos Group by 12,309.4% during the second quarter. Headlands Technologies LLC now owns 27,797 shares of the company’s stock worth $65,000 after purchasing an additional 27,573 shares during the period. CIBC Asset Management Inc bought a new position in shares of Cronos Group in the 2nd quarter worth about $87,000. Finally, Cedar Wealth Management LLC boosted its holdings in shares of Cronos Group by 65.4% in the 2nd quarter. Cedar Wealth Management LLC now owns 37,935 shares of the company’s stock valued at $88,000 after buying an additional 15,000 shares during the period. Institutional investors and hedge funds own 8.71% of the company’s stock.

About Cronos Group

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.